Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 receptor antagonist ELN441958

被引:23
作者
Hawkinson, Jon E.
Szoke, Balazs G.
Garofalo, Albert W.
Hom, Dennis S.
Zhang, Hongbing
Dreyer, Mark
Fukuda, Juri Y.
Chen, Linda
Samant, Bhushan
Simmonds, Stellanie
Zeitz, Karla P.
Wadsworth, Angie
Liao, Anna
Chavez, Raymond A.
Zmolek, Wes
Ruslim, Lany
Bova, Michael P.
Holcomb, Ryan
Butelman, Eduardo R.
Ko, Mei-Chuan
Malmberg, Annika B.
机构
[1] Elan Pharmaceut, Lead Discovery & Optimizat, San Francisco, CA 94080 USA
[2] Rockefeller Univ, Lab Biol Addict Dis, New York, NY 10021 USA
[3] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1124/jpet.107.120352
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The bradykinin B-1 receptor plays a critical role in chronic pain and inflammation, although efforts to demonstrate efficacy of receptor antagonists have been hampered by species-dependent potency differences, metabolic instability, and low oral exposure of current agents. The pharmacology, pharmacokinetics, and analgesic efficacy of the novel benzamide B-1 receptor antagonist 7-chloro-2-[3-(9-pyridin-4-yl-3,9-diazaspiro[ 5.5]undecanecarbonyl)phenyl]-2,3-dihydro-isoindol-1-one (ELN441958) is described. ELN441958 competitively inhibited the binding of the B-1 agonist ligand [3H]desArg(10-)kallidin ([3H]DAKD) to IMR-90 human fibroblast membranes with high affinity (K-i = 0.26 +/- 0.02 nM). ELN441958 potently antagonized DAKD ( but not bradykinin)-induced calcium mobilization in IMR-90 cells, indicating that it is highly selective for B-1 over B-2 receptors. Antagonism of agonist-induced calcium responses at B-1 receptors from different species indicated that ELN441958 is selective for primate over rodent B-1 receptors with a rank order potency (K-B, nanomolar) of human (0.12 +/- 0.02) similar to rhesus monkey (0.24 +/- 0.01) similar to rat (1.5 +/- 0.4) > mouse (14 +/- 4). ELN441958 had good permeability and metabolic stability in vitro consistent with high oral exposure and moderate plasma half-lives in rats and rhesus monkeys. Because ELN441958 is up to 120-fold more potent at primate than at rodent B1 receptors, it was evaluated in a primate pain model. ELN441958 dose-dependently reduced carrageenan-induced thermal hyperalgesia in a rhesus monkey tail-withdrawal model, with an ED50 similar to 3 mg/kg s.c. Naltrexone had no effect on the antihyperalgesia produced by ELN441958, indicating a lack of involvement of opioid receptors. ELN441958 is a novel small molecule bradykinin B-1 receptor antagonist exhibiting high oral bioavailability and potent systemic efficacy in rhesus monkey inflammatory pain.
引用
收藏
页码:619 / 630
页数:12
相关论文
共 43 条
[21]  
Ko MC, 1998, J PHARMACOL EXP THER, V285, P518
[22]  
KO MC, 2002, 10 WORLD C PAIN SEAT, P136
[23]   The role of central μ opioid receptors in opioid-induced itch in primates [J].
Ko, MCH ;
Song, MS ;
Edwards, T ;
Lee, H ;
Naughton, NN .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01) :169-176
[24]   2,3-diaminopyridine bradykinin B1 receptor antagonists [J].
Kuduk, SD ;
Ng, C ;
Feng, DM ;
Wai, JMC ;
Chang, RSL ;
Harrell, CM ;
Murphy, KL ;
Ransom, RW ;
Reiss, D ;
Ivarsson, M ;
Mason, G ;
Boyce, S ;
Tang, CY ;
Prueksaritanont, T ;
Freidinger, RM ;
Pettibone, DJ ;
Bock, MG .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (26) :6439-6442
[25]   Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats:: Distinct vasculopathic profile of major key organs [J].
Lawson, SR ;
Gabra, BH ;
Nantel, F ;
Battistini, B ;
Sirois, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 514 (01) :69-78
[26]   International union of pharmacology.: XLV.: Classification of the kinin receptor family:: from molecular mechanisms to pathophysiological consequences [J].
Leeb-Lundberg, LMF ;
Marceau, F ;
Müller-Esterl, W ;
Pettibone, DJ ;
Zuraw, BL .
PHARMACOLOGICAL REVIEWS, 2005, 57 (01) :27-77
[27]   Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain [J].
Levy, D ;
Zochodne, DW .
PAIN, 2000, 86 (03) :265-271
[28]   Partial agonists and full antagonists at the human and murine bradykinin B-1 receptors [J].
MacNeil, T ;
Feighner, S ;
Hreniuk, DL ;
Hess, JF ;
VanderPloeg, LHT .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (06) :735-740
[29]   Association between kinin B1 receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules [J].
McLean, PG ;
Ahluwalia, A ;
Perretti, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :367-380
[30]   The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B-1 receptors [J].
Meini, S ;
Lecci, A ;
Maggi, CA .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (08) :1619-1624